EE200000519A - Lämmastikoksiidi süntaasi inhibiitoritena toimivad halogeenitud amidinoaminohappederivaadid - Google Patents

Lämmastikoksiidi süntaasi inhibiitoritena toimivad halogeenitud amidinoaminohappederivaadid

Info

Publication number
EE200000519A
EE200000519A EEP200000519A EEP200000519A EE200000519A EE 200000519 A EE200000519 A EE 200000519A EE P200000519 A EEP200000519 A EE P200000519A EE P200000519 A EEP200000519 A EE P200000519A EE 200000519 A EE200000519 A EE 200000519A
Authority
EE
Estonia
Prior art keywords
amino acid
acid derivatives
nitric oxide
oxide synthase
synthase inhibitors
Prior art date
Application number
EEP200000519A
Other languages
English (en)
Estonian (et)
Inventor
Ann Hallinan E.
S. Pitzel Barnett
P. Spangler Dale
A. Bergmanis Arija
J. Hagen Timothy
Tsymbalov Sofya
V. Toth Mihaly
Keith Webber R.
W. Hansen Donald Jr.
K. Awasthi Alik
Original Assignee
G.D. Searle & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G.D. Searle & Co. filed Critical G.D. Searle & Co.
Publication of EE200000519A publication Critical patent/EE200000519A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
EEP200000519A 1998-03-11 1999-03-04 Lämmastikoksiidi süntaasi inhibiitoritena toimivad halogeenitud amidinoaminohappederivaadid EE200000519A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3828498A 1998-03-11 1998-03-11
PCT/US1999/003728 WO1999046240A2 (en) 1998-03-11 1999-03-04 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors

Publications (1)

Publication Number Publication Date
EE200000519A true EE200000519A (et) 2002-02-15

Family

ID=21899068

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000519A EE200000519A (et) 1998-03-11 1999-03-04 Lämmastikoksiidi süntaasi inhibiitoritena toimivad halogeenitud amidinoaminohappederivaadid

Country Status (35)

Country Link
US (1) US6344483B1 (es)
EP (2) EP1062201B1 (es)
JP (1) JP2002506056A (es)
KR (1) KR20010034598A (es)
CN (1) CN1171861C (es)
AP (1) AP2000001900A0 (es)
AR (1) AR018159A1 (es)
AT (1) ATE277894T1 (es)
AU (1) AU746235B2 (es)
BG (1) BG104766A (es)
BR (1) BR9908702A (es)
CA (1) CA2322873A1 (es)
CU (1) CU23047A3 (es)
DE (1) DE69920670T2 (es)
EA (1) EA200000826A1 (es)
EE (1) EE200000519A (es)
ES (1) ES2239839T3 (es)
GE (1) GEP20043179B (es)
HR (1) HRP20000595A2 (es)
HU (1) HUP0101467A3 (es)
ID (1) ID26208A (es)
IL (1) IL137654A0 (es)
IS (1) IS5583A (es)
NO (1) NO20004531L (es)
NZ (1) NZ506721A (es)
OA (1) OA11901A (es)
PL (1) PL343380A1 (es)
PT (1) PT1062201E (es)
SI (1) SI1062201T1 (es)
SK (1) SK13012000A3 (es)
TR (1) TR200002605T2 (es)
UA (1) UA67767C2 (es)
WO (1) WO1999046240A2 (es)
YU (1) YU52200A (es)
ZA (1) ZA991894B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE295832T1 (de) 2000-03-24 2005-06-15 Pharmacia Corp Amidino-verbindung sowie salze davon verwendbar als hemmstoffe der stickstoffmonoxid-synthase
US6545170B2 (en) 2000-04-13 2003-04-08 Pharmacia Corporation 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
AR034120A1 (es) 2000-04-13 2004-02-04 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
AR032318A1 (es) 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
AR030416A1 (es) 2000-04-13 2003-08-20 Pharmacia Corp COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA
US6787668B2 (en) 2000-04-13 2004-09-07 Pharmacia Corporation 2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
US6956131B2 (en) 2000-04-13 2005-10-18 Pharmacia Corporation 2-amino-3, 4 heptenoic compounds useful as nitric oxide synthase inhibitors
AR031129A1 (es) * 2000-09-15 2003-09-10 Pharmacia Corp Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
AR035585A1 (es) * 2000-09-15 2004-06-16 Pharmacia Corp Derivados del acido 2-amino-2-alquil-4-heptenoico, composicion farmaceutica y su uso en la fabricacion de medicamentos
AR031608A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
AR031609A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa
GB0031179D0 (en) 2000-12-21 2001-01-31 Glaxo Group Ltd Nitric oxide synthase inhibitors
US6582387B2 (en) * 2001-03-20 2003-06-24 Therox, Inc. System for enriching a bodily fluid with a gas
US6613280B2 (en) * 2001-03-20 2003-09-02 Therox, Inc. Disposable cartridge for producing gas-enriched fluids
US7012098B2 (en) 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
MXPA04011335A (es) * 2002-05-16 2005-07-01 Pharmacia Corp Metodos para el tratamiento de enfermedades y afecciones respiratorias con un inhibidor selectivo de inos y un inhibidor de pde y composiciones para esto.
US7385028B2 (en) * 2004-12-22 2008-06-10 Ambrx, Inc Derivatization of non-natural amino acids and polypeptides
MX2007011409A (es) * 2005-03-14 2008-02-22 Johnson & Johnson Procedimiento de preparacion de moduladores opioides.
SI1954710T1 (sl) 2005-11-08 2011-08-31 Ambrx Inc Pospeĺ evala za modifikacijo nenaravnih aminokislin in nenaravnih peptidov aminokislin
KR101423898B1 (ko) 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
KR101103720B1 (ko) * 2011-06-02 2012-01-11 한국건설기술연구원 자연환기에 의한 중공층의 온도제어가 가능한 일체형 다중유리 복합창짝
EP3043810B1 (en) 2013-09-09 2019-10-23 CanImGuide Therapeutics AB Immune system modulators
EP3265117B1 (en) 2015-03-06 2020-11-11 CanImGuide Therapeutics AB Immune system modulators and compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9312761D0 (en) 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
DK0957087T3 (da) 1994-06-15 2003-03-24 Wellcome Found Intermediater, der er anvendelige til fremstilling af enzym-inhibitorer
GB9425701D0 (en) 1994-12-20 1995-02-22 Wellcome Found Enzyme inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
CN1171861C (zh) 2004-10-20
ES2239839T3 (es) 2005-10-01
YU52200A (sh) 2002-09-19
NZ506721A (en) 2003-07-25
IL137654A0 (en) 2001-10-31
PT1062201E (pt) 2005-02-28
WO1999046240A2 (en) 1999-09-16
PL343380A1 (en) 2001-08-13
SI1062201T1 (en) 2005-10-31
DE69920670T2 (de) 2006-02-16
EP1415982A1 (en) 2004-05-06
AU746235B2 (en) 2002-04-18
JP2002506056A (ja) 2002-02-26
OA11901A (en) 2006-04-10
CA2322873A1 (en) 1999-09-16
SK13012000A3 (sk) 2001-06-11
AR018159A1 (es) 2001-10-31
NO20004531D0 (no) 2000-09-11
BR9908702A (pt) 2000-11-21
CU23047A3 (es) 2005-04-26
CN1292779A (zh) 2001-04-25
AU2778699A (en) 1999-09-27
HUP0101467A2 (hu) 2001-08-28
EP1062201B1 (en) 2004-09-29
TR200002605T2 (tr) 2000-12-21
UA67767C2 (uk) 2004-07-15
BG104766A (bg) 2001-03-30
GEP20043179B (en) 2004-02-25
ID26208A (id) 2000-11-07
NO20004531L (no) 2000-10-30
DE69920670D1 (de) 2004-11-04
AP2000001900A0 (en) 2000-09-30
HRP20000595A2 (en) 2001-04-30
ATE277894T1 (de) 2004-10-15
WO1999046240A3 (en) 1999-11-11
KR20010034598A (ko) 2001-04-25
ZA991894B (en) 1999-09-27
US6344483B1 (en) 2002-02-05
IS5583A (is) 2000-08-04
HUP0101467A3 (en) 2003-03-28
EA200000826A1 (ru) 2001-04-23
EP1062201A2 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
IS5723A (is) Nituroxíðs efnasmíða latar (Synthase Inhibitors)
EE9900281A (et) Lämmastikoksiidi süntaasi inhibiitorid
NO20004531D0 (no) Halogenerte amidinoaminosyre-derivater anvendbare som nitrogenoksid syntase inhibitorer
IS5053A (is) 6-Fenýlpýridýl-2-amín afleiður nytsamlegar sem nituroxíð sýntasa tálmar
NO20032835L (no) Nitrogenoksyd-syntase-inhibitor-fosfatsalt
AU4941501A (en) Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
AU2002222252A1 (en) Nitric oxide synthase inhibitor phosphate salt
AU4430599A (en) Inhibitors of nitric oxide synthase
DK1317421T3 (da) 2-amino-2-alkyl-5-heptensyre- og heptynsyrederivater der er nyttige som nitrogenoxidsynthaseinhibitorer
AU1308400A (en) Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors
EE9900474A (et) Amidiini derivaadid lämmastikoksiidi süntaasi inhibiitoritena
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
GB9810299D0 (en) Use of nitric oxide synthase inhibitors
AU2417601A (en) Amidine derivatives which are inhibitors of nitric oxide synthase
DK1062201T3 (da) Halogenerede amidinoaminosyrederivater anvendelige som nitrogenoxidsynthaseinhibitirer
AU4446500A (en) 5,7-bicyclic amidine derivatives useful as nitric oxide synthase inhibitors
AU2563601A (en) Amidine derivatives which are inhibitors of nitric oxide synthase
AU2001282829A1 (en) Amidine derivatives which are inhibitors of nitric oxide synthase
AU4329000A (en) Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
ZA971944B (en) Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors.
HK1025772A (en) Amidine derivatives as inhibitors of nitric oxide synthase
HK1061402A (en) Nitric oxide synthase inhibitor phosphate salt
SI0958277T1 (en) Nitric oxide synthase inhibitors
GB0031177D0 (en) Nitric oxide synthase inhibitors